PE20040770A1 - Aplicacion de inhibidores de recaptura intestinal de acido biliar para la prevencion y el tratamiento de la enfermedad de alzheimer - Google Patents
Aplicacion de inhibidores de recaptura intestinal de acido biliar para la prevencion y el tratamiento de la enfermedad de alzheimerInfo
- Publication number
- PE20040770A1 PE20040770A1 PE2003001247A PE2003001247A PE20040770A1 PE 20040770 A1 PE20040770 A1 PE 20040770A1 PE 2003001247 A PE2003001247 A PE 2003001247A PE 2003001247 A PE2003001247 A PE 2003001247A PE 20040770 A1 PE20040770 A1 PE 20040770A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- inhibitors
- compounds
- alzheimer
- disease
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Abstract
SE REFIERE A LA APLICACION DE COMPUESTOS INHIBIDORES DE LA RECAPTURA DE ACIDOS BILIARES EN LA PREVENCION Y TRATAMIENTO DE LA ENFERMEDAD DE ALZHEIMER. ESTOS COMPUESTOS SON DE FORMULA IA, EN DONDE R1, R4 Y R5 SON METILO, ETILO, PROPILO O BUTILO; R2 ES H, OH, NH2 o NH-ALQUILO(C1-C6); R3 ES UN MONOSACARIDO, BISACARIDO, TRISACARIDO O TETRASACARIDO, SIN SUSTITUIR O MONO O POLISUSTITUIDOS CON UN GRUPO PROTECTOR DE AZUCARES; Z ES (C=O)n-ALQUILO(C0-C16), (C=O)n-ALQUILO(C0-C16)-NH, (C=O)n-ALQUILO(C0-C16)-O, (C=O)n-ALQUILO(C0-16)-(C=O), O UN ENLACE COVALENTE; n Y m SON 0 o 1. Y DE FORMULA IB, EN DONDE R1 ES FENILO O HETEROARILO SUSTITUIDO O NO CON 1 A 3 RADICALES DE F, Cl, Br, I, OH, CF3, NO2, NHR9, NR9R10, CHO, CO2H, CO2R11, COR12, ALQUILO(C1-C6)-OH, ALQUILO (C1-C6)-OH-FENILO, ALQUILO(C1-C6)-CF3, ENTRE OTROS; R2 ES H, OH, CH2OH, -OMe, CHO o NH2; R4 ES H, METILO, F o O-ME; R9 A R12 SON H O ALQUILO(C1-C8); Z ES UN ENLACE COVALENTE, NH-ALQUILO(C0-C36)-CO O-ALQUILO(C0-C36)-CO, (CO)m-ALQUILO(C0-C36)-(CO)n, UN RESIDUO AMINOACIDO O DIAMINOACIDO, DONDE DICHOS RESIDUOS PUEDEN ESTAR MONO O POLISUSTITUIDO. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA ADMINISTRABLE POR VIA ORAL QUE CONTIENE DE 0,02 A 50 MG. DE ESTOS COMPUESTOS Y QUE PUEDEN ESTAR ASOCIADOS CON UNO O VARIOS COMPUESTOS COMO INHIBIDORES DE HMG-CoA-REDUCTASA, INHIBIDORES DE LA CAPTURA DE COLESTEROL, INHIBIDORES DE LA SINTESIS DE COLESTEROL O INHIBIDORES DE APP GAMA Y BETA-SECRETASAS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0215722A FR2848452B1 (fr) | 2002-12-12 | 2002-12-12 | Application des inhibiteurs de recapture intestinale des acides biliaires pour la prevention et le traitement de la maladie d'alzheimer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20040770A1 true PE20040770A1 (es) | 2004-12-10 |
Family
ID=32338722
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2003001247A PE20040770A1 (es) | 2002-12-12 | 2003-12-10 | Aplicacion de inhibidores de recaptura intestinal de acido biliar para la prevencion y el tratamiento de la enfermedad de alzheimer |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1572174A1 (es) |
| JP (1) | JP2006514063A (es) |
| KR (1) | KR20050084250A (es) |
| CN (1) | CN1726016A (es) |
| AR (1) | AR042354A1 (es) |
| AU (1) | AU2003296802A1 (es) |
| BR (1) | BR0317280A (es) |
| CA (1) | CA2507945A1 (es) |
| CO (1) | CO5700712A2 (es) |
| FR (1) | FR2848452B1 (es) |
| HR (1) | HRP20050534A2 (es) |
| MA (1) | MA27500A1 (es) |
| MX (1) | MXPA05005556A (es) |
| NO (1) | NO20053341L (es) |
| NZ (1) | NZ540496A (es) |
| PE (1) | PE20040770A1 (es) |
| PL (1) | PL377110A1 (es) |
| RS (1) | RS20050420A (es) |
| RU (1) | RU2005121909A (es) |
| TW (1) | TW200503707A (es) |
| WO (1) | WO2004062652A1 (es) |
| ZA (1) | ZA200504656B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7521481B2 (en) | 2003-02-27 | 2009-04-21 | Mclaurin Joanne | Methods of preventing, treating and diagnosing disorders of protein aggregation |
| ZA200603165B (en) | 2003-11-03 | 2007-07-25 | Probiodrug Ag | Combinations useful for the treatment of neuronal disorders |
| AU2005210004B2 (en) | 2004-02-05 | 2010-10-28 | Probiodrug Ag | Novel inhibitors of glutaminyl cyclase |
| WO2006050359A2 (en) | 2004-11-02 | 2006-05-11 | Northwestern University | Pyridazine compounds and methods |
| EP2015750A2 (en) | 2006-04-28 | 2009-01-21 | Northwestern University | Compositions and treatments using pyridazine compounds and cholinesterase inhibitors |
| EP2937085B1 (en) * | 2007-05-22 | 2019-07-10 | Otsuka Pharmaceutical Co., Ltd. | A medicament comprising a carbostyril derivative and donezepil for treating alzheimer's disease |
| CN107375932B (zh) | 2011-10-28 | 2021-12-21 | 夏尔人类遗传性治疗公司 | 用于治疗小儿胆汁淤积性肝病的胆汁酸再循环抑制剂 |
| EA029581B1 (ru) * | 2011-10-28 | 2018-04-30 | ЛУМЕНА ФАРМАСЬЮТИКАЛС ЭлЭлСи | Применение ингибиторов рециркуляции желчных кислот для лечения холестатического заболевания печени или прурита |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2040996A1 (en) * | 1990-05-02 | 1991-11-03 | Robert L. Albright | Composition and method for controlling cholesterol |
| CA2104594C (en) * | 1991-02-22 | 2004-05-11 | Howard K. Shapiro | Use of pharmaceutical compounds in the treatment of symptoms of disorders related to neurological diseases and etiologically related symptomology |
| AU3585397A (en) * | 1996-06-27 | 1998-01-14 | G.D. Searle & Co. | Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications |
| US5985936A (en) * | 1997-12-18 | 1999-11-16 | Forbes Medi-Tech, Inc. | Method of preventing and delaying onset of Alzheimer's disease and composition therefor |
| CA2311356C (en) * | 1998-01-28 | 2004-07-13 | Warner-Lambert Company | Method for treating alzheimer's disease |
| US6080778A (en) * | 1998-03-23 | 2000-06-27 | Children's Medical Center Corporation | Methods for decreasing beta amyloid protein |
| DE19825804C2 (de) * | 1998-06-10 | 2000-08-24 | Aventis Pharma Gmbh | 1,4-Benzothiepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| US6221897B1 (en) * | 1998-06-10 | 2001-04-24 | Aventis Pharma Deutschland Gmbh | Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use |
| DE19845405C2 (de) * | 1998-10-02 | 2000-07-13 | Aventis Pharma Gmbh | Arylsubstituierte Propanolaminderivate und deren Verwendung |
| WO2001056579A1 (en) * | 2000-02-04 | 2001-08-09 | Esperion Therapeutics Inc. | Methods for treating alzheimer's disease |
| US20020028826A1 (en) * | 2000-06-15 | 2002-03-07 | Robl Jeffrey A. | HMG-CoA reductase inhibitors and method |
| SE0104334D0 (sv) * | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
| TWI329111B (en) * | 2002-05-24 | 2010-08-21 | X Ceptor Therapeutics Inc | Azepinoindole and pyridoindole derivatives as pharmaceutical agents |
-
2002
- 2002-12-12 FR FR0215722A patent/FR2848452B1/fr not_active Expired - Fee Related
-
2003
- 2003-12-10 AU AU2003296802A patent/AU2003296802A1/en not_active Abandoned
- 2003-12-10 BR BR0317280-5A patent/BR0317280A/pt not_active IP Right Cessation
- 2003-12-10 NZ NZ540496A patent/NZ540496A/en unknown
- 2003-12-10 KR KR1020057010595A patent/KR20050084250A/ko not_active Application Discontinuation
- 2003-12-10 PE PE2003001247A patent/PE20040770A1/es not_active Application Discontinuation
- 2003-12-10 RU RU2005121909/15A patent/RU2005121909A/ru not_active Application Discontinuation
- 2003-12-10 JP JP2004566119A patent/JP2006514063A/ja not_active Abandoned
- 2003-12-10 MX MXPA05005556A patent/MXPA05005556A/es not_active Application Discontinuation
- 2003-12-10 RS YUP-2005/0420A patent/RS20050420A/sr unknown
- 2003-12-10 AR ARP030104540A patent/AR042354A1/es not_active Application Discontinuation
- 2003-12-10 EP EP03815109A patent/EP1572174A1/fr not_active Withdrawn
- 2003-12-10 CN CNA2003801059727A patent/CN1726016A/zh active Pending
- 2003-12-10 WO PCT/FR2003/003654 patent/WO2004062652A1/fr active Application Filing
- 2003-12-10 CA CA002507945A patent/CA2507945A1/fr not_active Abandoned
- 2003-12-10 PL PL377110A patent/PL377110A1/pl not_active Application Discontinuation
- 2003-12-11 TW TW092134949A patent/TW200503707A/zh unknown
-
2005
- 2005-06-07 ZA ZA200504656A patent/ZA200504656B/en unknown
- 2005-06-09 CO CO05056010A patent/CO5700712A2/es not_active Application Discontinuation
- 2005-06-10 MA MA28329A patent/MA27500A1/fr unknown
- 2005-06-10 HR HR20050534A patent/HRP20050534A2/xx not_active Application Discontinuation
- 2005-07-08 NO NO20053341A patent/NO20053341L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20050084250A (ko) | 2005-08-26 |
| CA2507945A1 (fr) | 2004-07-29 |
| CO5700712A2 (es) | 2006-11-30 |
| NO20053341L (no) | 2005-09-07 |
| NZ540496A (en) | 2008-04-30 |
| BR0317280A (pt) | 2005-11-08 |
| PL377110A1 (pl) | 2006-01-23 |
| AU2003296802A1 (en) | 2004-08-10 |
| JP2006514063A (ja) | 2006-04-27 |
| ZA200504656B (en) | 2006-08-30 |
| RU2005121909A (ru) | 2006-01-20 |
| NO20053341D0 (no) | 2005-07-08 |
| FR2848452B1 (fr) | 2007-04-06 |
| MXPA05005556A (es) | 2005-07-26 |
| RS20050420A (en) | 2007-04-10 |
| TW200503707A (en) | 2005-02-01 |
| EP1572174A1 (fr) | 2005-09-14 |
| MA27500A1 (fr) | 2005-08-01 |
| AR042354A1 (es) | 2005-06-15 |
| CN1726016A (zh) | 2006-01-25 |
| HRP20050534A2 (en) | 2006-11-30 |
| WO2004062652A1 (fr) | 2004-07-29 |
| FR2848452A1 (fr) | 2004-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2534546T3 (es) | Compuestos de piperidina, de tipo quinoxalina sustituida, y usos de los mismos | |
| CN1098262C (zh) | 光学活性的哌啶化合物的酸加成盐和其制备方法 | |
| PE20040770A1 (es) | Aplicacion de inhibidores de recaptura intestinal de acido biliar para la prevencion y el tratamiento de la enfermedad de alzheimer | |
| TW200833319A (en) | Crystalline forms | |
| UA101601C2 (uk) | Інгібітори амідогідролази жирних кислот | |
| AR039672A1 (es) | Dipeptido, derivado de benzotiazepina. inhibidor del transporte ileal de acidos biliares (ibat) | |
| PE20121314A1 (es) | Derivados de 4-aminociclohexano sustituido | |
| MX339144B (es) | Nuevas drogas para inhibir la agregacion de proteinas involucradas en enfermedades relacionadas con la agregacion de proteinas y/o enfermedades neurodegenerativas. | |
| RS53155B (en) | DIPEPTIDIL PEPTIDASE INHIBITOR ADMINISTRATION | |
| PE20081583A1 (es) | Agentes antibacterianos derivados de compuestos carbonilamino | |
| WO2008002573A3 (en) | Bile acid derivatives as fxr ligands for the prevention or treatment of fxr-mediated deseases or conditions | |
| UY28280A1 (es) | 2- hidroxi - 3- diaminoalcanos de benzamida | |
| PE20081389A1 (es) | Uso de profarmacos de analogos de gaba para tratar enfermedades | |
| CA2601808A1 (en) | Use of macelignan for treatment of brain diseases | |
| TW200806299A (en) | Treatment of pain | |
| AR041360A1 (es) | Proceso para la preparacion de valsartan | |
| RU2005105576A (ru) | Производные плевромутилина в качестве противомикроюных средств | |
| PE20080364A1 (es) | Acido bifenilcarboxilicos substituidos y sus derivados como moduladores de la actividad de la gamma-secretasa | |
| CA2472335A1 (en) | Geranyl compounds | |
| TW200604173A (en) | Novel compounds | |
| ES2278552T1 (es) | Preparacion de intermediarios de tadalafil. | |
| CN107709314A (zh) | 外排泵抑制剂及其治疗性用途 | |
| AR033300A1 (es) | Compuestos de cefem | |
| RU2009122481A (ru) | Эффективный способ получения соединений мугеиновой кислоты | |
| NO20092382L (no) | Radioaktivt diagnostiserende avbildningsmiddel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |